These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 15604241)
1. Cysteine cathepsins are central contributors of invasion by cultured adenosylmethionine decarboxylase-transformed rodent fibroblasts. Ravanko K; Järvinen K; Helin J; Kalkkinen N; Hölttä E Cancer Res; 2004 Dec; 64(24):8831-8. PubMed ID: 15604241 [TBL] [Abstract][Full Text] [Related]
2. TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells. Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E Am J Pathol; 2012 Dec; 181(6):2202-16. PubMed ID: 23063511 [TBL] [Abstract][Full Text] [Related]
3. Identification of integrins alpha6 and beta7 as c-Jun- and transformation-relevant genes in highly invasive fibrosarcoma cells. Kielosto M; Nummela P; Järvinen K; Yin M; Hölttä E Int J Cancer; 2009 Sep; 125(5):1065-73. PubMed ID: 19405119 [TBL] [Abstract][Full Text] [Related]
4. Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts. Janulis M; Silberman S; Ambegaokar A; Gutkind JS; Schultz RM J Biol Chem; 1999 Jan; 274(2):801-13. PubMed ID: 9873019 [TBL] [Abstract][Full Text] [Related]
5. [Cathepsins L and B and their endogenous inhibitors in embryonal fibroblasts transformed by different genes]. Dilakian EA; Vinokurova SV; Zhurbitskaia VA; Komissarova EV; Topol' LZ; Kiselev FL; Solov'eva NI Vopr Med Khim; 1998; 44(1):35-42. PubMed ID: 9575611 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Chambers AF; Colella R; Denhardt DT; Wilson SM Mol Carcinog; 1992; 5(3):238-45. PubMed ID: 1586450 [TBL] [Abstract][Full Text] [Related]
7. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes. Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654 [TBL] [Abstract][Full Text] [Related]
8. Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts. Sloane BF; Rozhin J; Moin K; Ziegler G; Fong D; Muschel RJ Biol Chem Hoppe Seyler; 1992 Jul; 373(7):589-94. PubMed ID: 1515088 [TBL] [Abstract][Full Text] [Related]
9. Sensitization to the lysosomal cell death pathway upon immortalization and transformation. Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336 [TBL] [Abstract][Full Text] [Related]
10. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells. Colella R; Casey SF Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846 [TBL] [Abstract][Full Text] [Related]
12. Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts. Achkar C; Gong QM; Frankfater A; Bajkowski AS J Biol Chem; 1990 Aug; 265(23):13650-4. PubMed ID: 2166039 [TBL] [Abstract][Full Text] [Related]
13. [Cysteine proteinases at various stages of neoplastic transformation of rat fibroblasts]. Dilakian EA; Solov'eva NI; Topol' LZ Vopr Med Khim; 1991; 37(6):36-9. PubMed ID: 1812612 [TBL] [Abstract][Full Text] [Related]
14. Thymosin beta4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblasts. Nummela P; Yin M; Kielosto M; Leaner V; Birrer MJ; Hölttä E Cancer Res; 2006 Jan; 66(2):701-12. PubMed ID: 16423999 [TBL] [Abstract][Full Text] [Related]
15. The role of cathepsin L in malignant transformation. Kane SE; Gottesman MM Semin Cancer Biol; 1990 Apr; 1(2):127-36. PubMed ID: 2103489 [TBL] [Abstract][Full Text] [Related]
16. Comparison of cathepsin L synthesized by normal and transformed cells at the gene, message, protein, and oligosaccharide levels. Stearns NA; Dong JM; Pan JX; Brenner DA; Sahagian GG Arch Biochem Biophys; 1990 Dec; 283(2):447-57. PubMed ID: 2275556 [TBL] [Abstract][Full Text] [Related]
17. Cathepsins B and L in synovial fluids from patients with rheumatoid arthritis and the effect of cathepsin B on the activation of pro-urokinase. Ikeda Y; Ikata T; Mishiro T; Nakano S; Ikebe M; Yasuoka S J Med Invest; 2000 Feb; 47(1-2):61-75. PubMed ID: 10740981 [TBL] [Abstract][Full Text] [Related]
18. [Expression of cathepsins D and L during neoplastic transformation of fibroblasts]. Dilakian EA; Balaevskaia TO; Zakamaldina-Tsama TA; Topol' LZ; Solov'eva NI Vopr Med Khim; 1994; 40(3):2-6. PubMed ID: 8079433 [TBL] [Abstract][Full Text] [Related]
19. Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. Kirschke H; Eerola R; Hopsu-Havu VK; Brömme D; Vuorio E Eur J Cancer; 2000 Apr; 36(6):787-95. PubMed ID: 10762753 [TBL] [Abstract][Full Text] [Related]
20. A distinctive repertoire of cathepsins is expressed by juvenile invasive Fasciola hepatica. Cancela M; Acosta D; Rinaldi G; Silva E; Durán R; Roche L; Zaha A; Carmona C; Tort JF Biochimie; 2008 Oct; 90(10):1461-75. PubMed ID: 18573308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]